| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 61 |
| 1 | SECUKINUMAB | 42 |
| 2 | PREDNISONE | 32 |
| 3 | USTEKINUMAB | 28 |
| 4 | METHOTREXATE SODIUM | 27 |
| 5 | METHOTREXATE | 26 |
| 6 | INFLIXIMAB | 24 |
| 7 | HYDROCHLOROTHIAZIDE | 23 |
| 8 | AZATHIOPRINE | 20 |
| 9 | ERGOCALCIFEROL | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SWIM-EAR | 1 | 0.0455 |
| 1 | EQUISETUM ARVENSE TOP | 1 | 0.0385 |
| 2 | FACTOR XIII CONCENTRATE (HUMAN) | 1 | 0.0110 |
| 3 | SODIUM MONOFLUOROPHOSPHATE | 2 | 0.0054 |
| 4 | CAFFEINE, MAGNESIUM SALICYLATE | 1 | 0.0039 |
| 5 | INFLIXIMAB-DYYB | 13 | 0.0038 |
| 6 | MENTHOL, METHYL SALICYLATE | 2 | 0.0033 |
| 7 | PAMABROM | 1 | 0.0027 |
| 8 | AMINOCAPROIC ACID | 2 | 0.0025 |
| 9 | PHENOBARBITAL SODIUM | 1 | 0.0024 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 55 |
| 1 | Corticosteroid [EPC] | 53 |
| 2 | Interleukin-17A Antagonist [EPC] | 44 |
| 3 | Benzodiazepine [EPC] | 43 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 42 |
| 5 | Interleukin-23 Antagonist [EPC] | 32 |
| 6 | Thiazide Diuretic [EPC] | 30 |
| 7 | Interleukin-12 Antagonist [EPC] | 28 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 26 |
| 9 | Purine Antimetabolite [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Interleukin-17A Antagonist [EPC] | 44 | 0.0012 |
| 2 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 3 | Provitamin D2 Compound [EPC] | 17 | 0.0006 |
| 4 | Interleukin-23 Antagonist [EPC] | 32 | 0.0003 |
| 5 | Antifibrinolytic Agent [EPC] | 3 | 0.0003 |
| 6 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 7 | Interleukin-12 Antagonist [EPC] | 28 | 0.0003 |
| 8 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 3 | 0.0002 |
| 9 | Purine Antimetabolite [EPC] | 21 | 0.0002 |